Viatris Inc (VTRS):企業の財務・戦略的SWOT分析

◆英語タイトル:Viatris Inc (VTRS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH31565FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:76
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Viatris Inc (VTRS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Viatris Inc (Viatris), formerly Mylan NV, is a healthcare company which develops, licenses, manufactures, markets and distributes generics and branded medicines, and consumer healthcare products. It offers pharmaceuticals in multiple forms for various disease conditions related to respiratory, cardiovascular, and central nervous system (CNS) system and allergy, skin disease, and cancer. It also offers anti-retrovirals, anaphylaxis products, and active pharmaceutical ingredients (APIs). The company sells its products to retail pharmacy chains, wholesalers and distributors, group purchasing organizations, drug store chains, independent pharmacies, drug manufacturers, institutions, and public and governmental agencies. The company markets its products in various countries worldwide. Viatris is headquartered in Canonsburg, Pennsylvania, the US.

Viatris Inc Key Recent Developments

Apr 12,2021: Viatris to Release First Quarter 2021 Financial Results on May 10, 2021
Mar 08,2021: Clinton Health Access Initiative and American Cancer Society announce agreement to expand Cancer Access Partnership
Mar 04,2021: Viatris to Participate in Barclays Global Healthcare Conference
Mar 01,2021: Viatris hosts Inaugural Investor Day outlining unique and differentiated business model, High-quality operational platform, and focus on CSR and financial commitments
Feb 22,2021: Viatris announces 2021 financial guidance and reaffirms strategic and financial commitments

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Viatris Inc – Key Facts
Viatris Inc – Key Employees
Viatris Inc – Key Employee Biographies
Viatris Inc – Major Products and Services
Viatris Inc – History
Viatris Inc – Company Statement
Viatris Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Viatris Inc – Business Description
Business Segment: Greater China
Overview
Geographical Segment: Developed Markets
Target Markets
Performance
Overview
Geographical Segment: Emerging Markets
Target Markets
Performance
Overview
Geographical Segment: Greater China
Target Markets
Performance
Geographical Segment: JANZ
Target Markets
Performance
Overview
Geographical Segment: Other Revenue
Performance
R&D Overview
Viatris Inc – Corporate Strategy
Viatris Inc – SWOT Analysis
SWOT Analysis – Overview
Viatris Inc – Strengths
Viatris Inc – Weaknesses
Viatris Inc – Opportunities
Viatris Inc – Threats
Viatris Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Viatris Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Viatris Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Viatris Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 12, 2021: Viatris to Release First Quarter 2021 Financial Results on May 10, 2021
Mar 08, 2021: Clinton Health Access Initiative and American Cancer Society announce agreement to expand Cancer Access Partnership
Mar 04, 2021: Viatris to Participate in Barclays Global Healthcare Conference
Mar 01, 2021: Viatris hosts Inaugural Investor Day outlining unique and differentiated business model, High-quality operational platform, and focus on CSR and financial commitments
Feb 22, 2021: Viatris announces 2021 financial guidance and reaffirms strategic and financial commitments
Jan 28, 2021: FTC approves final order imposing conditions on combination of Pfizer’s Upjohn and Mylan N.V.
Dec 11, 2020: Viatris announces additional details of previously disclosed global restructuring initiative
Dec 07, 2020: Sesame Workshop and Viatris launch global resources to help children and caregivers manage social and emotional needs during upcoming holiday season and beyond
Nov 16, 2020: Pfizer completes transaction to combine its Upjohn business with mylan
Nov 16, 2020: Viatris launches as a new kind of healthcare company, positioned to meet the world’s evolving healthcare needs
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Viatris Inc, Key Facts
Viatris Inc, Key Employees
Viatris Inc, Key Employee Biographies
Viatris Inc, Major Products and Services
Viatris Inc, History
Viatris Inc, Other Locations
Viatris Inc, Subsidiaries
Viatris Inc, Key Competitors
Viatris Inc, Ratios based on current share price
Viatris Inc, Annual Ratios
Viatris Inc, Annual Ratios (Cont...1)
Viatris Inc, Annual Ratios (Cont...2)
Viatris Inc, Interim Ratios
Viatris Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Viatris Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Viatris Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Viatris Inc (VTRS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dance Biopharm Inc:医療機器:M&Aディール及び事業提携情報
    Summary Dance Biopharm Inc (Dance Biopharm), a subsidiary of Dance Biopharm Holdings Inc, formerly Dance Pharmaceuticals Inc, is a biotechnology company that develops inhaled insulin products to treat diabetes patients. The company provides product pipeline such as Dance-501, a pocket-sized inhaler …
  • Golden Valley Mines Ltd. (GZZ):企業の財務・戦略的SWOT分析
    Golden Valley Mines Ltd. (GZZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Koninklijke KPN NV (KPN):企業の財務・戦略的SWOT分析
    Koninklijke KPN NV (KPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Perstorp Holding AB:企業の戦略的SWOT分析
    Perstorp Holding AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Glenmark Pharmaceuticals Limited:企業のM&A・事業提携・投資動向
    Glenmark Pharmaceuticals Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Glenmark Pharmaceuticals Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • University of California Berkeley-製薬・医療分野:企業M&A・提携分析
    Summary University of California Berkeley (UC Berkeley), a subsidiary of University of California is an educational university that offers educational programs and research services. The university’s academic programs comprise law and economics program, legal studies; lesbian, gay, bisexual, and tra …
  • Taiflex Scientific Co Ltd (8039):企業の財務・戦略的SWOT分析
    Taiflex Scientific Co Ltd (8039) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Sunvault Energy Inc:電力:M&Aディール及び事業提携情報
    Summary Sunvault Energy Inc (Sunvault Energy) is a renewable energy company that provides solar energy products and solutions. The company provides products such as solar energy products, renewable energy products, water and sewer equipment, wind power generation equipment, solar power generation eq …
  • Singapore Telecommunications Ltd:企業の戦略・SWOT・財務情報
    Singapore Telecommunications Ltd - Strategy, SWOT and Corporate Finance Report Summary Singapore Telecommunications Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • NexTier Oilfield Solutions Inc (NEX):企業の財務・戦略的SWOT分析
    NexTier Oilfield Solutions Inc (NEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Tauron Polska Energia SA:企業の発電所・SWOT分析2018
    Tauron Polska Energia SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • ATS Automation Tooling Systems Inc (ATA):企業の財務・戦略的SWOT分析
    ATS Automation Tooling Systems Inc (ATA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • eFFECTOR Therapeutics Inc:企業のM&A・事業提携・投資動向
    eFFECTOR Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's eFFECTOR Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Theraclion SA (ALTHE):企業の財務・戦略的SWOT分析
    Summary Theraclion SA (Theraclion) is a medical device company that designs, markets, and develops high-intensity focused therapeutic ultrasound devices and equipment; and offers technical support services. The company offers echotherapy solution that combines HIFU therapy with ultrasound as a syste …
  • Protea Biosciences Group Inc (PRGB):企業の財務・戦略的SWOT分析
    Summary Protea Biosciences Group Inc (Protea) operates as a biotechnology company that develops mass spectometry solutions. The company offers technology for identification, characterization, and quantitation of biologically-important molecules for pharmaceutical development, research, and diagnosti …
  • Ei Towers SpA:企業の戦略・SWOT・財務情報
    Ei Towers SpA - Strategy, SWOT and Corporate Finance Report Summary Ei Towers SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Cohu Inc (COHU):企業の財務・戦略的SWOT分析
    Cohu Inc (COHU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Milestone Scientific Inc (MLSS):企業の財務・戦略的SWOT分析
    Summary Milestone Scientific Inc (Milestone Scientific) is a medical device company that designs, manufactures and distributes computer controlled drug delivery instruments in the medical and dental fields. The company’s medical specialties include anesthesiology, pain medicine, orthopedic surgery, …
  • Bio Techne Corp (TECH)-医療機器分野:企業M&A・提携分析
    Summary Bio Techne Corp (Bio Techne), develops manufactures and sells biotechnology products and instruments for research and clinical diagnostics. The company provides proteins and antibodies, and related immunoassays and other reagents for research under brands such as R&D Systems, Novus, Biologic …
  • Edwards Lifesciences Corporation:企業の戦略・SWOT・財務情報
    Edwards Lifesciences Corporation - Strategy, SWOT and Corporate Finance Report Summary Edwards Lifesciences Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆